CON	Blood
NTH	Quest
NIL	WASHINGTON
NIL	,
UNK	DC
NIL	–
REL	In
INT	most
IST	developed
CON	countries
NIL	,
CON	patients
POS	can
EXS	be
IST	confident
AND	about
DEF	the
CON	safety
AND	of
CON	blood
CON	transfusions
NIL	.
DEF	The
CON	problem
NOW	is
SUB	that
EXS	maintaining
DIS	a
IST	steady
NIL	,
EXS	uncontaminated
CON	supply
AND	of
IST	donor
CON	blood
NOW	is
NOT	not
IST	always
EXS	easy
NIL	.
NOW	Is
PRO	it
EXS	possible
SUB	to
EXS	ensure
DIS	an
IST	adequate
CON	supply
AND	of
IST	safe
CON	blood
AND	once
AND	and
REL	for
AND	all
QUE	?
NOW	Today
DEF	’s
CON	blood
CON	supplies
EQU	,
IST	often
PST	donated
REL	by
CON	volunteers
NIL	,
POS	can
EXS	be
EXS	contaminated
REL	with
UNK	HIV
AND	and
ALT	other
IST	infectious
CON	agents
NIL	.
AND	And
IST	donor
CON	blood
NEC	must
EXS	be
EXS	kept
REL	in
IST	cold
CON	storage
NIL	,
SUB	where
PRO	it
NOW	has
DIS	a
IST	28-day
CON	shelf
CON	life
NIL	.
AND	Given
CON	fear
AND	of
CON	contamination
NIL	–
AND	and
IST	military
CON	interest
REL	in
DIS	a
MOR	more
IST	durable
CON	supply
AND	–
CON	research
REL	into
IST	synthetic
CON	alternatives
NOW	has
IST	long
EXS	been
DIS	a
IST	medical
CON	priority
NIL	.
DEF	The
CON	idea
AND	of
EXS	using
CON	blood
CON	substitutes
PST	was
IST	first
EXS	advanced
REL	in
DEF	the
IST	seventeenth
CON	century
NIL	,
COO	and
ENS	continues
SUB	to
EXS	attract
CON	researchers
NOW	today
NIL	.
IST	Several
CON	products
AND	that
POS	could
EXS	revolutionize
CON	transfusion
CON	medicine
NOW	have
IST	already
PFT	been
EXS	developed
REL	in
DEF	the
CON	pursuit
AND	of
IST	shelf-stable
EQU	,
IST	portable
EQU	,
IST	one-type-fits-all
CON	blood
CON	substitutes
NIL	,
UNK	which
POS	could
EXS	replace
IST	standard
CON	blood
CON	transfusions
REL	in
IST	extreme
CON	situations
NIL	,
AND	such
AND	as
REL	on
DEF	the
CON	battlefield
NIL	.
AND	But
NIL	,
REL	after
MOR	more
MOR	than
QUC	three
CON	decades
AND	of
IST	active
CON	research
AND	and
CON	development
NIL	,
NOT	no
IST	clinically
IST	viable
CON	product
NOW	has
EXS	obtained
IST	regulatory
CON	approval
NIL	,
EXS	owing
REL	to
DEF	the
IST	significant
IST	scientific
CON	challenges
NIL	.
CON	Blood
NOW	is
DIS	a
IST	complicated
CON	stew
AND	of
CON	plasma
CON	proteins
EQU	,
IST	red
CON	blood
CON	cells
EQU	,
CON	platelets
NIL	,
AND	and
ALT	other
IST	cellular
CON	components
NIL	.
PRX	These
CON	elements
NOW	perform
IST	crucial
CON	functions
NIL	,
AND	such
AND	as
CON	transporting
CON	oxygen
EQU	,
CON	nutrients
NIL	,
AND	and
CON	immunoglobulins
NIL	(
AND	which
EXS	defend
AND	against
CON	infection
NIL	)
NIL	,
COO	and
EXS	regulating
CON	water
CON	content
EQU	,
CON	temperature
NIL	,
COO	and
PRO	pH
CON	level
NIL	.
REL	In
DEF	the
IST	early
IST	twentieth
CON	century
NIL	,
CON	researchers
EPS	began
SUB	to
EXS	examine
CON	hemoglobin
AND	–
DEF	the
CON	protein
IST	responsible
REL	for
EXS	carrying
CON	oxygen
REL	from
DEF	the
IST	respiratory
CON	organs
REL	to
DEF	the
CON	rest
AND	of
DEF	the
CON	body
NIL	–
REL	in
IST	red
CON	blood
CON	cells
NIL	.
PRO	They
EPS	found
SUB	that
NIL	,
SUB	when
EXS	isolated
REL	from
EXG	aging
CON	cells
NIL	–
SUB	whether
REL	from
IST	human
DIS	or
CON	cow
CON	blood
EQU	,
DIS	or
REL	from
INT	genetically
EXT	engineered
CON	sources
AND	–
IST	free
CON	hemoglobin
POS	can
EXS	be
EXS	rejuvenated
NIL	,
EXS	chemically
EPS	stabilized
NIL	,
COO	and
EXS	re-infused
AND	as
DIS	a
CON	blood
NIL	“
CON	substitute
NIL	”
AND	that
POS	can
EXS	carry
CON	oxygen
AND	as
IST	effectively
AND	as
IST	red
CON	blood
CON	cells
NIL	,
BUT	but
REL	for
DIS	a
QUC	much
MOR	shorter
CON	time
NIL	.
SUB	(
IST	Non-hemoglobin
IST	synthetic
CON	blood
CON	substitutes
NIL	,
EXS	known
AND	as
CON	fluorocarbons
NIL	,
NOW	have
EXS	proved
SUB	to
EXS	be
MOR	less
IST	effective
CON	oxygen
CON	carriers
NIL	.
NIL	)
AND	But
IST	free
CON	hemoglobin
POS	can
EXS	wreak
CON	havoc
REL	in
DEF	the
IST	human
CON	body
NIL	,
EXS	causing
CON	hypertension
EQU	,
IST	cardiac
CON	arrest
EQU	,
DIS	or
IST	even
CON	death
NIL	.
